Explore
The Burden of Respiratory Syncytial Virus Infection in the Young
0 Ungluers have
Faved this Work
Login to Fave
Respiratory syncytial virus (RSV) causes seasonal epidemics during the winter and wet seasons, particularly in young children. Although there is one drug available for prophylaxis, palivizumab, it is indicated for high-risk children only. Therefore a vaccine is urgently needed. This book provides an overview of RSV and discusses its incidence and presentation in different populations, including preterm infants and children with congenital heart disease. It also discusses future strategies for RSV prophylaxis and developments in and barriers to creating a viable vaccine.
This book is included in DOAB.
Why read this book? Have your say.
You must be logged in to comment.
Rights Information
Are you the author or publisher of this work? If so, you can claim it as yours by registering as an Unglue.it rights holder.Downloads
This work has been downloaded 17 times via unglue.it ebook links.
- 17 - pdf (CC BY) at mts.intechopen.com.
Keywords
- Clinical & internal medicine
- Dermatology
- medicine
- Respiratory medicine
Links
DOI: 10.5772/intechopen.78206Editions